Navigation Links
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
Date:12/3/2008

SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced an exclusive, binding letter of intent with EIP Eczacibasi Ilac Pazarlama A.S. (EIP) for sales and marketing of the company's Allovectin-7(R) immunotherapeutic product candidate in Turkey and the Turkish Republic of Northern Cyprus. EIP has agreed to obtain the necessary regulatory approvals for the territory and to pay Vical upfront and milestone payments plus a specified transfer price in exchange for the rights to an exclusive license for the territory. EIP is a leading Turkish pharmaceutical company and has multiple licensing agreements with major biotech and pharmaceutical companies including Amgen, Pfizer, Procter & Gamble, and sanofi-aventis.

Vijay B. Samant, Vical's President and Chief Executive Officer, said, "As we advance toward completion of enrollment in our Phase 3 trial of Allovectin-7(R) in patients with advanced metastatic melanoma, we are also looking ahead to commercialization opportunities in key global markets. As an established pharmaceutical company in Turkey with a significant cancer franchise, EIP has the expertise to guide Allovectin-7(R) through the Turkish approval process and the strength to launch and sell Allovectin-7(R) successfully in the Turkish market. We continue to explore licensing and distribution agreements in additional international markets."

About Allovectin-7(R)

Allovectin-7(R) is a plasmid/lipid complex containing the DNA sequences encoding HLA-B7 and beta-2 microglobulin, which together form a Class I Major Histocompatibility Complex, or MHC-I antigen. Injection of Allovectin-7(R) directly into tumors is designed to stimulate an immune response against both local and distant metastatic tumors. Vical conducted a large Phase 2 trial evaluating Allovectin-7(R) immunothera
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
2. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
3. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
4. Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
5. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
6. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
7. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
9. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
10. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014   Ventana Medical ...  Group, today announced that its VENTANA System for ... in the European Union for routine pathology, including ... consisting of VENTANA Virtuoso software coupled with either ... HT slide scanner, provides automated digital slide creation, ...
(Date:8/20/2014)... CITY , Aug. 20, 2014 ApolloDx™ ... mobile diagnostic platform during a special event at the ... , on September 5, 2014. The event, which ... on the ApolloDx website, www.apollodx.com .    ... diagnostic testing," said Jared Bauer , Co-Founder and ...
(Date:8/20/2014)... DIEGO , Aug. 20, 2014 Trovagene, ... diagnostics, announced today that results from two clinical studies ... conference for the Company,s urine-based diagnostic test for the ... The IPV conference is scheduled to take place in ... to 25 th . Additionally, a new U.S. ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3
(Date:8/20/2014)... Fresh from the cradle of a world-class running city, ... blocks. , Urbini, a new collection of versatile baby gear ... jogger to its lineup. , The Avi has been ... by the latest racing styles and a set of features ... offers a swift, smooth ride on runs, power-walks and causal ...
(Date:8/20/2014)... 2014 Doctors at the University of Hong ... mesothelioma in laboratory mice by injecting them with a vaccine ... of the study on its website. Click here to ... Kong University’s AIDS Institute of Microbiology created a vaccine using ... By altering DNA, the vaccine is designed to prevent mesothelioma ...
(Date:8/20/2014)... Parents and kids across the nation ... months means buying textbooks and arranging after school care, ... forgotten part of the annual re-commitment to your child’s ... Psychological Association, 27% of students say they experience "extreme ... they are stressed by school pressures. The study, Stress ...
(Date:8/20/2014)... 2014 New Jersey’s Medical Marijuana Program ... estimated tens of thousands of patients in the state. ... bill that would expand the list of qualifying conditions ... this summer by State Assemblywoman Linda Stender, the need ... is growing. , To help fill the information gap ...
(Date:8/20/2014)... The report “Automotive Airbag and ... Global Analysis: by Geography - Trends and Forecasts ... defines automotive airbag and seatbelt market in terms ... growth opportunities in the coming years as well ... restrains, growth indicators, challenges, legislation trends, market dynamics, ...
Breaking Medicine News(10 mins):Health News:Urbini Breezes Through Summer with New Jogging Stroller 2Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 2Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 3Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 2Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 4
... in Memory: Why Some Birthdays Are Harder to Remember ... and Shigehiro Oishi People may have a better ... Volunteers recalling their friends, birthdays tended to remember birthdays ... were farther away from their own birthday. In a ...
... By Serena Gordon HealthDay Reporter , TUESDAY, Nov. ... reports being adequately trained to deal with asthma symptoms in kids, ... two coaches knew more than one asthma symptom, according to the ... meeting of the American College of Chest Physicians, in Vancouver, Canada. ...
... Wash.November 2, 2010The Allen Institute for Brain Science ( ... which includes new data and tools for exploring genes ... expanding and enhancing the Allen Human Brain Atlas, the ... Ivy Glioblastoma Atlas Project and the NIMH Transcriptional Atlas ...
... Randy Dotinga HealthDay Reporter , TUESDAY, Nov. 2 ... Science may be onto you. Researchers report that they,ve ... differently when they,re trying to manipulate others into believing something ... The findings hint at how complicated bluffing is compared ...
... may be responsible for up to one-third of strokes ... all cases of blood clots in large veins, and ... trials have been conducted involving people with APS, and ... To stimulate an international discussion on this topic, the ...
... CA (November 1, 2010)Breast cancer, one of the most ... each year and causes about 40,000 deaths annually. The ... through lymphovascular invasion (LVI)a process in which cancer cells ... translate into a poor prognosis for patients. Some ...
Cached Medicine News:Health News:New research from Psychological Science 2Health News:New research from Psychological Science 3Health News:New research from Psychological Science 4Health News:Many Coaches Unprepared for Student-Athletes' Asthma 2Health News:Many Coaches Unprepared for Student-Athletes' Asthma 3Health News:20th public data release by Allen Institute for Brain Science 2Health News:20th public data release by Allen Institute for Brain Science 3Health News:Study Unmasks the Biology of Bluffing 2Health News:International summit held to stimulate collaborative clinical research on antiphospholipid syndrome 2Health News:Fox Chase researchers identify risk factors for the spread of breast cancer to lymph nodes 2
The focus of HandEchart Professional is to offer a practical and basic electronic patient record keeping system that anyone can learn in minutes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
A handy, quick reference for physicians, nurses, and other health care providers treating cancer patients....
A handy quick-reference tool for busy residents and clinicians with key facts and points essential for day-to-day patient care....
Medicine Products: